by RNA | Apr 20, 2022 | Client Success, Strategic Advisory, Valuation Advisory
By Jeff Williamson THE SITUATION: A healthcare company with a portfolio of products in development for treating cardiac conditions was fielding investor interest for a potential acquisition. The company wanted to weigh the relative merits of raising additional equity... Read More
by RNA | Apr 20, 2022 | Client Success, Valuation Advisory
By Jeff Suchocki, CFA The Situation: Adoption of ASC 842 – Lease Accounting is mandatory for all private companies for fiscal years beginning after December 15, 2021. To comply with this mandatory adoption requirement, a privately held, clinical stage biotech company... Read More
by RNA | Nov 10, 2020 | Client Success, Strategic Advisory, Valuation Advisory
THE PROBLEM: A healthcare technology company that sells its FDA 510(k) approved device and supporting dashboarding and analytic tools to hospitals was in the midst of a capital raising effort involving a one-on-one negotiation with an existing strategic partner. The... Read More
by RNA | Jul 25, 2019 | Client Success, Strategic Advisory, Valuation Advisory
THE PROBLEM: A publicly traded clinical stage biotech company needed to understand the correct implied discount rate for a lease agreement in accordance with ASC 842 rules. THE SOLUTION: ASC 842 has specific rules relating to leases, including guidance on lease... Read More
by RNA | Jul 12, 2017 | Valuation Advisory
Value is ultimately what parties agree to. Sometimes this seems rational, other times irrational. The reality is that value often results from the ability or inability to create an effective bidding process and to persuade/anchor a strategic counterparty toward your... Read More
by RNA | Jul 11, 2017 | Valuation Advisory
In finance, theories about the efficiency of markets have been both extraordinarily elegant and disastrously wrong on many occasions. These so-called efficient markets concepts have brought about interesting tools like the Capital Asset Pricing Model and Black-Scholes... Read More
